cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.14338946
title: Supplementary Material for: Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in Clinical Practice of Single Center: Three-Year Outcomes

description: <b><i>Introduction:</i></b> The objective of this study was to explore visual and anatomical outcomes in patients who underwent intravitreal anti-vascular endothelial growth factor (anti-VEGF) injection for visual impairment from center-involved diabetic macular edema (CI-DME) in clinical practice. <b><i>Methods:</i></b> Medical records of consecutive CI-DME patients who initiated treatment with intravitreal bevacizumab injection between January 2012 and December 2016 and were followed for at least 12 months were retrospectively reviewed. Visual and anatomical changes after treatment over a 36-month period were evaluated. <b><i>Results:</i></b> There were 286 patients (423 eyes) with a mean (standard deviation, SD) age of 56.8 (8.5) years included in this study. One hundred and forty-six (51%) patients were female, and 137 (47.9%) patients received bilateral eye treatment. Mean (SD) presenting visual acuity (VA) of overall eyes was 50.2 (19.6) letter scores. Stratified by baseline vision, eyes with initial VA worse than 20/40 achieved a statistically significant VA improvement, compared to baseline, by +8.4, +6.9, and +5.4 letters at 12, 24, and 36 months, respectively, with all <i>p</i> values &lt;0.001. However, when initial VA was 20/40 and better, a non-statistically significant change in mean VA by +2.0, −3.5, and −3.6 letters were noted at the same time point (<i>p</i> value between 0.078 and 0.273). Unlike visual changes, a statistically significant decline in central subfield thickness compared to baseline was noted at the end of months 12, 24, and 36 in both initial VA subgroups (all <i>p</i> values &lt;0.001). Nevertheless, even though the median number of given injections considerably decreased from 6 in the first 12 months to 2 in the second 12-month period and 1 in the final 12-month interval, required ophthalmic clinic visits decreased in frequency with median numbers of 10, 7, and 6 appointments in each consecutive 12-month duration. <b><i>Conclusion:</i></b> This study supports the benefits of practical intravitreal anti-VEGF utilization to manage CI-DME in real-world settings. The improvement of vision in eyes presenting with poor baseline VA and maintenance of vision in eyes with better baseline VA were demonstrated through the 3-year review of each case. However, the burden of frequent monitoring warrants further evaluation of long-term compliance and efficacy.
DOI: 10.6084/m9.figshare.14338946.v1
title: Supplementary Material for: Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in Clinical Practice of Single Center: Three-Year Outcomes

description: <b><i>Introduction:</i></b> The objective of this study was to explore visual and anatomical outcomes in patients who underwent intravitreal anti-vascular endothelial growth factor (anti-VEGF) injection for visual impairment from center-involved diabetic macular edema (CI-DME) in clinical practice. <b><i>Methods:</i></b> Medical records of consecutive CI-DME patients who initiated treatment with intravitreal bevacizumab injection between January 2012 and December 2016 and were followed for at least 12 months were retrospectively reviewed. Visual and anatomical changes after treatment over a 36-month period were evaluated. <b><i>Results:</i></b> There were 286 patients (423 eyes) with a mean (standard deviation, SD) age of 56.8 (8.5) years included in this study. One hundred and forty-six (51%) patients were female, and 137 (47.9%) patients received bilateral eye treatment. Mean (SD) presenting visual acuity (VA) of overall eyes was 50.2 (19.6) letter scores. Stratified by baseline vision, eyes with initial VA worse than 20/40 achieved a statistically significant VA improvement, compared to baseline, by +8.4, +6.9, and +5.4 letters at 12, 24, and 36 months, respectively, with all <i>p</i> values &lt;0.001. However, when initial VA was 20/40 and better, a non-statistically significant change in mean VA by +2.0, −3.5, and −3.6 letters were noted at the same time point (<i>p</i> value between 0.078 and 0.273). Unlike visual changes, a statistically significant decline in central subfield thickness compared to baseline was noted at the end of months 12, 24, and 36 in both initial VA subgroups (all <i>p</i> values &lt;0.001). Nevertheless, even though the median number of given injections considerably decreased from 6 in the first 12 months to 2 in the second 12-month period and 1 in the final 12-month interval, required ophthalmic clinic visits decreased in frequency with median numbers of 10, 7, and 6 appointments in each consecutive 12-month duration. <b><i>Conclusion:</i></b> This study supports the benefits of practical intravitreal anti-VEGF utilization to manage CI-DME in real-world settings. The improvement of vision in eyes presenting with poor baseline VA and maintenance of vision in eyes with better baseline VA were demonstrated through the 3-year review of each case. However, the burden of frequent monitoring warrants further evaluation of long-term compliance and efficacy.
DOI: 10.6084/m9.figshare.12199017
title: Data supporting the review article: Efficacy and Safety of Hydroxychloroquine and Chloroquine for Treating COVID-19: A Rapid Review

description: NOTE: there is no peer-reviewed publication associated with this data record.<br>This data record consists of a single data file <b>Chloroquine or hydroxychloroquine for COVID 19 (1).rm5</b>, in <b>.rm5</b> file format.<br>The file contains the data for forest plots, risk of bias, and summary of findings for the efficacy and safety of hydroxychloroquine and chloroquine.<br><b>Aims and methodology</b>: The related review aimed to determine the efficacy and safety of hydroxychloroquine and chloroquine given as a single drug or in combination with standard care with or without any other antimicrobial agent.The authors searched the PubMed, CENTRAL, Google Scholar, Chinese clinical trial registry, and trial registers: ISRCTN; UMIN-CTR (Japan's Trial Register); the WHO portal up to 9th April 2020 using the search terms *chloroquine, hydroxychloroquine, coronavirus, SARS-Cov-2, 2019-NCov, and COVID-19.For data collection and analysis, the standard Cochrane methods were employed.For more details on the methodology, please read the related article.<br><b>Software needed to access data:</b> The .rm5 file requires the RevMan software to be accessed.<br>
DOI: 10.6084/m9.figshare.12199017.v1
title: Data supporting the review article: Efficacy and Safety of Hydroxychloroquine and Chloroquine for Treating COVID-19: A Rapid Review

description: NOTE: there is no peer-reviewed publication associated with this data record.<br>This data record consists of a single data file <b>Chloroquine or hydroxychloroquine for COVID 19 (1).rm5</b>, in <b>.rm5</b> file format.<br>The file contains the data for forest plots, risk of bias, and summary of findings for the efficacy and safety of hydroxychloroquine and chloroquine.<br><b>Aims and methodology</b>: The related review aimed to determine the efficacy and safety of hydroxychloroquine and chloroquine given as a single drug or in combination with standard care with or without any other antimicrobial agent.The authors searched the PubMed, CENTRAL, Google Scholar, Chinese clinical trial registry, and trial registers: ISRCTN; UMIN-CTR (Japan's Trial Register); the WHO portal up to 9th April 2020 using the search terms *chloroquine, hydroxychloroquine, coronavirus, SARS-Cov-2, 2019-NCov, and COVID-19.For data collection and analysis, the standard Cochrane methods were employed.For more details on the methodology, please read the related article.<br><b>Software needed to access data:</b> The .rm5 file requires the RevMan software to be accessed.<br>
DOI: 10.6084/m9.figshare.14338949
title: Table S1

description: Table S1
DOI: 10.6084/m9.figshare.14338949.v1
title: Table S1

description: Table S1
DOI: 10.6084/m9.figshare.14338961
title: Table S3

description: Table S3
DOI: 10.6084/m9.figshare.14338961.v1
title: Table S3

description: Table S3
DOI: 10.6084/m9.figshare.14338964.v1
title: Table S1

description: Table S1
DOI: 10.6084/m9.figshare.14338964
title: Table S1

description: Table S1
DOI: 10.6084/m9.figshare.14338970
title: Table S3

description: Table S3. References for Table S1 and S2
DOI: 10.6084/m9.figshare.14338970.v1
title: Table S3

description: Table S3. References for Table S1 and S2
DOI: 10.34808/f7e0-3n79
title: Electrochemical cell impedance spectra at Eoc

description: The dataset presents impedance spectrum of electrochemical cell filled with 3% NaCl solution presented in the figure below. This cell was used measured using Atlas-Sollich 0531 impedance analyser with built-in potentiostat. When changing the DC polarisation of the cell the non-linear phenomena could be observed. The impedance spectrum frequency range (10 mHz – 100 kHz) was selected. At this dataset the DC polarisation was set to Eoc (open circuit potential) + 0mV.   Figure top-left presents impedance modulus and Figure top-right presents impedance angle for the cell presented in Figure bottom-left for different DC polarisation, in this dataset for Eoc + 0 mV.
The cell is filled with 3% solution of NaCl, the carbon steel working electrode was used, the counter electrode was made with platinium mesh and silver chloride reference electrode was applied.
DOI: 10.34808/f4yr-hr24
title: Electrochemical cell impedance spectra at Eoc+100mV

description: The dataset presents impedance spectrum of electrochemical cell filled with 3% NaCl solution presented in the figure below. This cell was used measured using Atlas-Sollich 0531 impedance analyser with built-in potentiostat. When changing the DC polarisation of the cell the non-linear phenomena could be observed. The impedance spectrum frequency range (10 mHz – 100 kHz) was selected. At this dataset the DC polarisation was set to Eoc (open circuit potential) + 100mV.  Figure top-left presents impedance modulus and Figure top-right presents impedance angle for the cell presented in Figure bottom-left for different DC polarisation, in this dataset for Eoc + 100 mV.
The cell is filled with 3% solution of NaCl, the carbon steel working electrode was used, the counter electrode was made with platinium mesh and silver chloride reference electrode was applied.
DOI: 10.34808/ampr-y717
title: Electrochemical cell impedance spectra at Eoc+200mV

description: The dataset presents impedance spectrum of electrochemical cell filled with 3% NaCl solution presented in the figure below. This cell was used measured using Atlas-Sollich 0531 impedance analyser with built-in potentiostat. When changing the DC polarisation of the cell the non-linear phenomena could be observed. The impedance spectrum frequency range (10 mHz – 100 kHz) was selected. At this dataset the DC polarisation was set to Eoc (open circuit potential) + 200mV.  Figure top-left presents impedance modulus and Figure top-right presents impedance angle for the cell presented in Figure bottom-left for different DC polarisation, in this dataset for Eoc + 200 mV.
The cell is filled with 3% solution of NaCl, the carbon steel working electrode was used, the counter electrode was made with platinium mesh and silver chloride reference electrode was applied.
DOI: 10.34808/28e5-b311
title: Electrochemical cell impedance spectra at Eoc-100mV

description: The dataset presents impedance spectrum of electrochemical cell filled with 3% NaCl solution presented in the figure below. This cell was used measured using Atlas-Sollich 0531 impedance analyser with built-in potentiostat. When changing the DC polarisation of the cell the non-linear phenomena could be observed. The impedance spectrum frequency range (10 mHz – 100 kHz) was selected. At this dataset the DC polarisation was set to Eoc (open circuit potential) - 100mV.  Figure top-left presents impedance modulus and Figure top-right presents impedance angle for the cell presented in Figure bottom-left for different DC polarisation, in this dataset for Eoc - 100 mV.
The cell is filled with 3% solution of NaCl, the carbon steel working electrode was used, the counter electrode was made with platinium mesh and silver chloride reference electrode was applied.
DOI: 10.34808/qj5b-rh22
title: Electrochemical cell impedance spectra at Eoc-200mV

description: The dataset presents impedance spectrum of electrochemical cell filled with 3% NaCl solution presented in the figure below. This cell was used measured using Atlas-Sollich 0531 impedance analyser with built-in potentiostat. When changing the DC polarisation of the cell the non-linear phenomena could be observed. The impedance spectrum frequency range (10 mHz – 100 kHz) was selected. At this dataset the DC polarisation was set to Eoc (open circuit potential) - 200mV.  Figure top-left presents impedance modulus and Figure top-right presents impedance angle for the cell presented in Figure bottom-left for different DC polarisation, in this dataset for Eoc - 200 mV.
The cell is filled with 3% solution of NaCl, the carbon steel working electrode was used, the counter electrode was made with platinium mesh and silver chloride reference electrode was applied.
DOI: 10.6084/m9.figshare.12446120
title: Data on epidemiological and clinical characteristics of coronavirus-infected (COVID-19) individuals in Iran

description: NOTE: there is no peer-reviewed publication associated with this data record.<br><br>This data record contains a single dataset, <b>Statistics200.xls</b>, in .xls file format.<br>The dataset contains information on 1142 patients suspected of having coronavirus. Data collection was performed using interviews, inserting information into the researcher-made questionnaires, and using the information in patients' medical records.<br>The dataset consists of 52 individual variables. Empty cells correspond to data that are not available for that patient. The variables are: age, gender, citizenship, taken to the hospital (1; no, 2; yes), section of hospital, contact coronadisease (0; no history of contact with COVID-19 patients, 1; history of contact with COVID-19 patients), sample for test (0; patient did not provide a sample for the PCR COVID test, 1; patient provided a sample for the PCR test), result PCR (0; negative for COVID-19, 1; positive for COVID-19, 3; test result is pending), The following symptoms were reported, for which 0 stands for absence of symptom, and 1 stands for presence of the symptom: fever, cough, myalgia or fatigue, shortness of breath, loss of consciousness, smell, taste, convulsions, headache, dizziness, limb paresis, limb plexus, chest pain, skin lesions, other signs, gastrointestinal, nausea, vomiting, diarrhea, anorexia), CT scan manifestation (0; CT scan results for COVID-19 are negative, 1; CT scan results for COVID-19 are positive), smoking, use of opium, patient has undergone intubation, rate of partial pressure of oxygen, Po2 (0; PO2 levels are greater than 93, 2; PO2 levels are less than 93), presence of underlying diseases (cancer, liver disease, hematologic disease, diabetes, HIV/AIDS, immune deficiency (acquired or congenital), pregnancy, heart disease, renal disease, dialysis status, asthma, Chronic obstructive pulmonary disease (COPD)), other chronic diseases, hypertension, condition when entering the hospital, death, duration of hospitalisation in days.<br><br><b>Study aims and methodology</b>: The new Coronavirus disease (COVID-19) primarily targets the human respiratory system, and represents a public health emergency and global concern. The present study aimed to investigate the epidemiological and clinical characteristics of COVID-19, in Saveh city, of Iran, in 2020.The present study was descriptive-analytical research in which all 1142 patients suspected of having coronavirus, who visited Saveh Medical Centers from February 9 to April 1 7, 2020, were included in the study. Data collection was performed using interviews, inserting information into the researcher-made questionnaires, and using the information in patients' medical records. Data were analyzed by SPSS 21 using Chi-square, independent sample t tests, Fisher's Exact Test, and regression analysis.For more details on the methodology, please read the related article.<br>
DOI: 10.34808/cdd9-be22
title: Long-term hindcast simulation of sea ice in the Baltic Sea

description: The data set contains the results of numerical modeling of sea ice over a period of 50 years (1958-2007) in the Baltic Sea. A long-term hindcast simulation was performed using a three-dimensional hydrodynamic model PM3D (Kowalewski and Kowalewska-Kalkowska, 2017), a new version of the M3D model (Kowalewski, 1997). A numerical dynamic-thermodynamic model of sea ice (Herman et al. 2011) was coupled to the analysis of ice conditions variability.
The model is based on the Princeton Ocean Model (POM) developed at Princeton University (Blumberg and Mellor, 1987). Like POM, the M3D/PM3D model uses the Mellor-Yamada turbulence scheme and sigma vertical coordinates. The simulation was carried out in a rectangular grid of 3' (latitude) and 6' (longitude) resolution. The spatial resolution was 3 nautical miles, i.e. about 5.5 km. An open boundary was located between the Skagerrak and the Kattegat along the parallel connecting Skagen and Göteborg, where the water exchange with the North Sea takes place. A radiation condition based on Somerfield’s concept for velocities  vertically averaged and normal to the boarder  plane was applied. Atmospheric forcing for the period 1958-2007 was performed using the regional at amospheric climate model REMO (REgional MOdel) which was based on the numerical weather prediction model EM (Europa-Model) of the German Weather Forecast Service (DWD).
Daily spatial distributions of sea ice thickness and concentration were recorded in the model's computational grid in unprojected form (LatLong, WGS 84, EPSG: 4326). Ice thickness is expressed in meters and ice concentration (fraction) is expressed as the ratio of the ice covered area to the total area of the grid. The results of quantitative comparisons between simulated ice concentrations and satellite data (Herman et al. 2011) were considered satisfactory.
DOI: 10.6084/m9.figshare.14339006
title: data-Typhoon control of hydrogen and oxygen isotopes of precipitation in South China and its palaeoenvironmental implications.xlsx

description: Long-term rainwater samples were collected, including samples from 413 precipitation events (with 144 rainwater samples from a total of 43 typhoon events) from May 2015 to April 2020 in Zhanjiang, a tropical city frequently affected by typhoon events in South China. The moisture sources, the correlation between <i>δ</i>D and <i>δ</i><sup>18</sup>O, and their relationships with climate conditions were investigated. Those data may provide new insight into the responses of <i>δ</i>D and <i>δ</i><sup>18</sup>O in precipitation to climatic and/or environmental variables in South China, as well as their palaeoenvironmental significance.
DOI: 10.34808/s5ek-kt08
title: Testing impedance analyzer with potentiostat using RC model with Si diode at 600 mV

description: The dataset presents impedance spectrum non-linear RC model with diode presented in the figure below. This model was used as a test engine of the impedance analyzer with potentiostat described in the referenced paper. When changing the DC polarisation of the model the non-linear phenomena could be observed. Thanks to this, the model can be used as a test engine for evaluation of the analyzer in the non-linearity conditions. The impedance spectrum frequency range (10 mHz – 100 kHz) was selected in order to test the whole measureement range of the analyzer. At this dataset the DC polarisation was set to 600mV. Details could be found in the refereced paper.  Figure top-left presents impedance modulus and Figure top-right presents impedance angle for the model presented in Figure bottom-left for different DC polarisation, in this dataset for 600 mV.
DOI: 10.34808/dtdv-es49
title: Testing impedance analyzer with potentiostat using RC model with Si diode at 400 mV

description: The dataset presents impedance spectrum non-linear RC model with diode presented in the figure below. This model was used as a test engine of the impedance analyzer with potentiostat described in the referenced paper. When changing the DC polarisation of the model the non-linear phenomena could be observed. Thanks to this, the model can be used as a test engine for evaluation of the analyzer in the non-linearity conditions. The impedance spectrum frequency range (10 mHz – 100 kHz) was selected in order to test the whole measureement range of the analyzer. At this dataset the DC polarisation was set to 400mV. Details could be found in the refereced paper.  Figure top-left presents impedance modulus and Figure top-right presents impedance angle for the model presented in Figure bottom-left for different DC polarisation, in this dataset for 400 mV.
DOI: 10.34808/x3p7-8765
title: Testing impedance analyzer with potentiostat using RC model with Si diode at 200 mV

description: The dataset presents impedance spectrum non-linear RC model with diode presented in the figure below. This model was used as a test engine of the impedance analyzer with potentiostat described in the referenced paper. When changing the DC polarisation of the model the non-linear phenomena could be observed. Thanks to this, the model can be used as a test engine for evaluation of the analyzer in the non-linearity conditions. The impedance spectrum frequency range (10 mHz – 100 kHz) was selected in order to test the whole measureement range of the analyzer. At this dataset the DC polarisation was set to 200mV. Details could be found in the refereced paper.  Figure top-left presents impedance modulus and Figure top-right presents impedance angle for the model presented in Figure bottom-left for different DC polarisation, in this dataset for 200 mV.
DOI: 10.34808/qsv8-v072
title: Testing impedance analyzer with potentiostat using RC model with Si diode at 0 V

description: The dataset presents impedance spectrum non-linear RC model with diode presented in the figure below. This model was used as a test engine of the impedance analyzer with potentiostat described in the referenced paper. When changing the DC polarisation of the model the non-linear phenomena could be observed. Thanks to this, the model can be used as a test engine for evaluation of the analyzer in the non-linearity conditions. The impedance spectrum frequency range (10 mHz – 100 kHz) was selected in order to test the whole measureement range of the analyzer. In this dataset, the DC polarisation was set to 0 mV. Details could be found in the refereced paper.  Figure top-left presents impedance modulus and Figure top-right presents impedance angle for the model presented in Figure bottom-left for different DC polarisation, in this dataset for 0 mV.
DOI: 10.5281/zenodo.4646784
title: Mechanical Behaviors of Hydrate-bearing Sediment with Different Cementation Spatial Distributions at Microscales

description: <strong>Supplemental Information</strong> Table S1. Datasets related to the pore space radii distribution in Figure 1. Table S2. Datasets related to the stress-strain relationship in Figure 2. Table S3. Datasets related to the hydrate particle number and average size evolution in Figure 5. Table S4. Datasets related to the PNM parameter evolution in Figure 7. Table S5. Datasets related to the hydrate-sand interfacial area evolution in Figure 8. Movie S1. Movie related to the deformation process of the specimen #O-1. Movie S2. Movie related to the deformation process of the specimen #O-2.